Purpose: To describe the retinal structure of a group of patients affected by methylmalonic aciduria with homocystinuria cblC type, caused by mutations in the MMACHC gene, using spectral domain optical coherence tomography (SD-OCT). Methods: Young patients (n = 11, age 0-74 months) with cblC disease, detected by newborn screening or clinically diagnosed within 40 days of life, underwent molecular analysis and complete ophthalmic examination, including fundus photography and SD-OCT. In one case, we also performed fluorescein angiography (FA) and standard electroretinography (ERG). Results: Molecular analysis of the MMACHC gene fully confirmed cblC disease in nine of 11 patients. Two patients harboured only a single heterozygous pathogenic MMACHC mutation and large unbalanced rearrangements were excluded by array-CGH analysis in both. All patients except two showed a bilateral maculopathy. In general, retinal changes were first observed before one year of age and progressed to a well-established maculopathy. Measurable visual acuities ranged from normal vision, in keeping with age, to bilateral, severe impairment of central vision. Nystagmus was present in six patients. Spectral Domain optical coherence tomography (SD-OCT) showed macular thinning with severe alterations in outer, and partial sparing of inner, retinal layers. Conclusion: Patients affected by cblC disease may frequently show an early onset maculopathy with variable ophthalmoscopic appearance. Spectral Domain optical coherence tomography (SD-OCT) broadens the knowledge of subtle retinal alterations during the disease's progression and helps to shed light on the pathological mechanism of maculopathy development.
Introduction
Methylmalonic aciduria with homocystinuria, cobalamin C type (MMA with Hcy cblC, cblC disease) (OMIM 277400), is the most common inborn error of intracellular vitamin B12 (cobalamin) metabolism and results in impaired biosynthesis of adenosylcobalamin and methylcobalamin, which are the coenzymes of the enzymes methylmalonyl-CoA mutase and methionine synthase, respectively. Reduced activity of these two enzymes leads to increased concentration of methylmalonic acid and homocysteine in plasma and urine, together with normal or decreased concentration of methionine in plasma.
The CblC disease is an inherited autosomal recessive disorder due to mutations in the MMACHC gene ) and can cause a wide variety of symptoms including developmental, neurological, haematologic, ophthalmologic, dermatologic and renal abnormalities (Huemer et al. 2017) . Depending on the age of onset, patients are classified into early-onset (≤1 year) and late-onset (>1 year) forms .
Ophthalmologic manifestations are very frequent in cblC patients and range from optic atrophy to various degree of maculopathy or panretinal disease (Patton et al. 2000; Morel et al. 2006; Schimel & Mets 2006; Gizicki et al. 2014; Aleman et al. 2015; Weisfeld-Adams et al. 2015) . Ocular disease can severely affect quality of life in cblC patients and is more common among early-onset forms (WeisfeldAdams et al. 2015) . The pathophysiologic mechanisms underlying ocular features of cblC disease have not yet been defined. Various forms of maculopathy are described in the literature (Tsina et al. 2005; Gaillard et al. 2008; Francis et al. 2010 ) but, to date, there is limited knowledge regarding the basis of retinal alteration and there is only speculation regarding the pathogenesis of retinopathy (Tsina et al. 2005; Gerth et al. 2008; Francis et al. 2010) .
Although infantile mortality has decreased considerably, it is well recognized that a growing population of cblC patients develop complications despite treatment (Huemer et al. 2017) . Specifically for the ocular disease, patients with early-onset form have frequently a progressive visual loss leading to blindness in the first decade of life, even if the optimized therapy with hydroxycobalamin and betaine is started early (Fischer et al. 2014) . Late-onset patients rarely have a severe visual disease (Gerth et al. 2008; Fischer et al. 2014 ), but minimal pigmentary retinal abnormalities may be present (Gerth et al. 2008; Weisfeld-Adams et al. 2015) . The classical 'bull's eye' picture has only been described in one late-onset cblC patient (Collison et al. 2015) .
To better understand the origins of the visual dysfunction and retinal structural abnormalities resulting from cblC disease, we studied a group of very young patients with cblC disease using measures of central vision, electrophysiology and evaluation of the retinal structure with SD-OCT.
Materials and Methods

Patients
Ten very young patients (age at SD-OCT examination between 5 days and 6 years) diagnosed with cblC disease at the Meyer Children's Hospital of Florence (n = 10), and one patient (age at examination 8 months) at the Jules Gonin Eye Hospital, Lausanne, Switzerland (n = 1), was included in this study. All patients were diagnosed early; five of them were detected by expanded newborn screening (NBS); in the remaining cases, the diagnosis was made within 40 days of life after a clinical/biochemical assessment (Table 1 ). All patients were supplemented with hydroxycobalamin, betaine, folates and levocarnitine since the diagnosis.
Molecular analysis
Genomic DNAs of the patients and their parents were isolated from peripheral blood using a QIAsymphony instrument (Qiagen, Hilden, Germany), after obtaining informed consent for genetic testing. The entire coding region and intron-exon boundaries of the MMACHC gene (NCBI RefSeq: NM_015506.2) were amplified by polymerase chain reaction (PCR). PCR primers and conditions are available on request. PCR fragments were purified using Exo-SAP-IT (USB Corporation, Cleveland, OH, USA) and then were sequenced using the BigDye Terminator v1.1 Cycle Sequencing Kit and an ABI PRISM 3130 Genetic Analyser (Applied Biosystems, Foster City, CA, USA) as recommended by the manufacturer.
Ophthalmic examination
A monthly fundus examination with indirect ophthalmoscopy was performed from the diagnosis of the disease until the first year of life for all but one patient, with subsequent follow-up visits every 6 months. A SD-OCT, 6-mmlength cross-line scan of the macular area, was performed under general anaesthesia at the time of neurological imaging (MRI scan) with hand-held SD-OCT (I-VUE, Optovue, Fremont, CA, USA) at the Meyer Children's Hospital for 10/11 patients, with a median age of 24 months (range 0-74 months). In one patient, the examination under anaesthesia was performed at the Jules Gonin Eye Hospital with SD-OCT (Bioptigen Inc, Durham, NC), FA, retinography (RetCam 2 Clarity Medical Systems Inc., Pleasanton, CA) and standard ERG (RETI-port32; Roland, Consult, Brandeburg, Germany) in accordance with the ISCEV (International Society for clinical Electrophysiology) guidelines. Where available, the optical coherence tomography (OCT) scans were associated with retinal fundus imaging (Topcon TRC-NW300 NonMydriatic Retinal Camera; RetCam 3 Clarity Medical Systems Inc., Pleasanton, CA) to correlate the OCT with the ophthalmoscopic appearance. The OCT acquisition was performed using the cross-line protocol (I-VUE software) centred on the fovea. We used OCT lexicon as reported in a recent paper (Staurenghi et al. 2014) to describe the localization of retinal alterations. The study adhered to the tenets of the Declaration of Helsinki; informed consent was obtained from the parents of patients. The approval of an institutional review board (IRB) was not required in participating institutions.
Results
All patients with Caucasian origin belong to unrelated families, and they had a negative history for ocular or metabolic disorders or for consanguinity.
Molecular analysis identified biallelic causal mutations in the MMACHC gene of nine of 11 patients (Table 2) . Two patients harboured only a single heterozygous pathogenic MMACHC gene mutation. In both these patients, bidirectional sequence analysis of the entire coding region and intron-exon boundaries of the MMACHC gene did not identify any additional variant of uncertain significance (VUS) and large unbalanced rearrangements were excluded by array-CGH analysis. All mutations were previously described (Komhoff et al. 2013 ) . The c.271dupA (p.Arg91Lysfs*14) was the most common mutation in this series of patients, accounting for 68% of mutant alleles. The genotype of eight of 11 patients was associated with early cblC onset: five patients were homozygous for c.271dupA, and three patients were compound heterozygotes for c.271dupA and the mutations c.331C>T (p.Arg111*), c.457C>T (p.A rg153*) and c.666C>A (p.Tyr222*), respectively. P2 resulted compound heterozygous for the c.271dupA and the synonymous mutation c.276G>A (p.Glu92Glu). The c.276G>A has been previously described at a heterozygous state with the null mutation c.14_2 4del11 in a patient with initial presentation of the disease at 14 years (Komhoff et al. 2013) , and thus, it is associated with a late-onset phenotype. As the c.276G>A did not change the amino acid sequence of the MMACHC protein (i.e. synonymous mutation), but affected the last nucleotide of exon 2, Komhoff et al. (2013) assumed that it resulted in a splicing error. We evaluated the effect of c.276G>A substitution by in silico analysis using the Alamut Visual (http://www.interactivebiosoftware.com) and Mutpred Splice (http://www.mutdb.org/mutpredsplice/ about.htm) tools. Both tools predicted a splicing alteration caused by c.276G>A by a loss of the natural donor site. All MMACHC mutations identified in the probands were confirmed at a heterozygous state in their parents.
Nystagmus was noted in six of 11 patients; nine of 11 patients developed maculopathy during the first year of age. The predominant refractive error was a bilateral mild astigmatism ( Table 2 ). The central retinal ophthalmoscopic appearance ranged from no abnormalities to pigmentary changes and atrophic lesions (Fig. 3) . The areas of atrophy showed a parafoveal distribution as a 'bull's eye' maculopathy or well-delimited central chorioretinal atrophy with, or without, posterior depression of the base of the lesion and the appearance of a pseudo-coloboma (Fig. 2) . The optic nerve appeared normal in all patients. Standard ERG was performed during evaluation under general anaesthesia and showed a 50% reduction in scotopic awave and a delay of photopic and scotopic b-wave consistent with the presence of a diffuse photoreceptor and bipolar cell dysfunction.
P1 (23 months): The horizontal scan evidenced a preserved nerve fibre layer (NFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL) and outer nuclear layer (ONL), but the loss of the external limiting membrane (ELM), the myoid, the ellipsoid and the interdigitation zone with preservation of the RPE/ Bruch complex in the foveal area.
P2 (74 months): Horizontal and vertical scans evidenced normal retinal morphology.
P3 (20 months): The horizontal scan was obtained slightly eccentrically from the fovea. We noted a preserved NFL with a thinning of GCL, IPL, preservation of INL and severely reduced OPL and disruption of outer retinal layers until the RPE/Bruch membrane complex. We noted the presence of hyper-reflective material in the foveal area. The alterations are clearer in the vertical scan centred on the fovea. P4 (12 months): A preserved NFL, GCL, IPL and INL were present in the horizontal scan, while a severely reduced OPL was noted. Outer retinal layers were disrupted with the presence of hyper-reflective material in the parafoveal area, anterior to the RPE/ Bruch membrane complex. P5 (0 months): We performed retinal imaging and SD-OCT at five days of life (Fig. 1) , after confirmation of the cblC diagnosis, and at 21 months of life during sedation for an MRI scan. In the first OCT, the horizontal scan showed preservation of a normal, yet immature, retinal structure in keeping with the patient's age (Vajzovic et al. 2012; Maldonado et al. 2010 ). In the vertical scan, we detected the presence of cystic spaces within the INL inferior to the fovea and the IPL is dipped downwards. Retinal indirect ophthalmoscopy was unremarkable at the first evaluation, but had become consistent with a 'bull's eye' and pseudocoloboma-like maculopathy at 8 months, subsequently confirmed by fundus photography and SD-OCT at 21 months (Fig. 2) . P6 (20 months): We noted a preserved NFL, GCL, IPL and INL. In the OCT horizontal scan, a thinning of the OPL and ONL was evident with total disruption of outer retinal layers and an accumulation of hyper-reflective material anterior to the RPE/Bruch membrane complex in the macular region.
P7 (58 months): We noted a slightly preserved NFL, GCL, IPL and INL with disruption of the OPL, ONL, myoid, ellipsoid and interdigitation zone in the macular region. The RPE/ Bruch membrane complex was preserved with accumulation of hyperreflective material.
P8 (15 months): A preserved NFL, GCL, IPL and INL were present, and a severely reduced OPL and ONL with the loss of the myoid, ellipsoid and e779 interdigitation zone in the macular region. The RPE/Bruch membrane complex was preserved. P9 (11 months): The horizontal scan showed NFL, GCL, IPL and INL preservation with a severely reduced OPL, ONL and the loss of the myoid, ellipsoid and interdigitation zone in the macular region with only the preservation of the RPE/Bruch membrane complex. P10 (0 months): We performed retinal imaging and SD-OCT at five days of life. The SD-OCT horizontal scan showed preservation of a normal, yet immature, retinal structure in keeping with the patient's age. The funduscopic appearance showed a normal macular area with diffuse retinal haemorrhages that disappeared a few days after birth.
P11 (8 months): The funduscopic appearance showed a salt and pepper retinopathy at the posterior pole with a 'bull's eye'-like appearance on FA (Fig. 3) . The SD-OCT showed preservation of NFL, GCL, IPL and INL with a severely reduced OPL and ONL. A complete loss of the myoid, ellipsoid and interdigitation zones involved the entire macular area. The foveal thickness was reduced to 97 microns in RE and 104 microns in LE. A choroidal thickening of 468 microns in RE and 457 microns in LE was noted. The standard ERG shows only a mild decrease in a-wave in photopic response and a delay of b-wave in both scotopic and photopic responses, indicating a mild cone-rod dystrophy
Discussion
Methylmalonic aciduria with homocystinuria cblC is a multisystemic metabolic disease affecting cobalamin metabolism. The presence of retinal alterations in cblC is a common feature and it is reported to develop more frequently and into a more severe form in the early-onset phenotype (Gerth et al. 2008 ), suggesting to some extent a correlation with the biochemical phenotype. However, current treatment does not seem to modify the progression of visual disease significantly (Huemer et al. 2017) .
In 2010, Francis et al. postulated that the alteration in the reuptake mechanism of methionine in the cone cell membrane during the phototransduction process, with subsequent low levels of intracellular methionine, could be the main factor in the onset of maculopathy. Although rod cell sensitivity was reported to improve in a patient with cblC disease following normalization of plasma methionine levels (Tsina et al. 2005) , generally the retinal dysfunction can be progressive and even lead to blindness despite treatment and stabilized systemic function (Fischer et al. 2014) .
In 2014, Aleman described OCT findings in a 13-year-old child affected by early-onset cblC sharing a similar description of some of our cases (Aleman et al. 2015) .
All published papers, including recent papers (Bonafede et al. 2015; Brooks et al. 2016; Ku et al. 2016) , conclude that the clinical evolution of retinopathy is not prevented by the early administration of systemic therapy aimed at reducing levels of the toxic metabolites (Tsina et al. 2005; Gerth et al. 2008) .
Our study confirms the data in the literature: ocular manifestations in cblC are more common in early-onset forms of the disease, retinopathy evolution is not prevented by early treatment with hydroxycobalamin or betaine, and there is a wide heterogeneity in clinical ocular findings ranging from no retinal alterations to diffuse and atrophic changes at the posterior pole. It is interesting to note that many patients showed hyperreflective material in outer retinal layers (Fig. 4) : this is probably related to macrophageal activity, raising the possibility that the primary damage is in the deep retinal structures. The SD-OCT was taken under sedation in all patients included in the study allowing maximum resolution of retinal layers. However, the limited sample size and the fact that OCT scans were mainly obtained only after maculopathy was established (except for P2, P5 and P10) do not allow us to make a precise localization of the first disturbance.
The common c.271dupA mutation, identified as a homozygous change or in a compound heterozygous state with other early-onset mutations, is frequently associated with a severe ocular phenotype. One patient from our series (P10) with a genotype responsible for early-onset cblC [c.272dupA (p.Arg 91Lysfs*14)/c.331C>T
(p.Arg111*)] does not manifest maculopathy at the moment (14 months of age). This suggests that the variable ocular phenotype may depend on other factors besides MMACHC mutations, such as age at examination, polymorphisms in other genes, oxidative stress, therapy and environmental or epigenetic factors.
The OCT scan for patient 5 was obtained very early in life (5 days old). The first examination revealed intraretinal cystic spaces as the only ophthalmic abnormality, but by 8 months, a visible funduscopic change was notable and confirmed by OCT during the examination under anaesthesia (Fig. 2) . The normal appearance of the OCT immediately after birth leads to speculation about when the process that causes maculopathy starts. Bonafede et al. (2015) stated in their paper that it is possible that the maturation of the central retina is the moment when the pathological perturbation in cblC disease occurs. This hypothesis is supported by our patient's normal OCT and the normal ophthalmoscopic appearance at 5 days of age and by the subsequent development of a maculopathy after a few months of life, which occurred despite the prompt administration of systemic therapy.
Patient 2, who was carrying mutations associated with late-onset cblC, did not develop any sign of maculopathy and the OCT, performed at 6 years of life, showed a normal development of both macular structures with normal visual acuity (VA). However, as maculopathy has been also described in late-onset cblC, although more rarely than in early-onset forms (Rosenblatt et al. 1997) , it is too early to conclude that this patient will not develop a progressing ophthalmic disease.
Our data shed more light on OCTbased morphological changes in cblC disease that seems to follow a pattern during the first months of life: it begins with very little o no retinal abnormalities until a well-established maculopathy that become manifest around the 8 th month, although the age of onset could be high variable and unpredictable. Other authors describe a similar evolution and similar OCT alterations that disrupt outer and inner retinal layers (Aleman et al. 2015; Weisfeld-Adams et al. 2015; Brooks et al. 2016) in accordance with the hypothesis that cblC disease affects a normal retinal development with a mechanism not yet understood.
To our knowledge, this is the largest series of very young paediatric patients with cblC disease yet described and characterized with high resolution OCT.
Based on the results of this study, we conclude that more than one pattern of maculopathy can develop in MMA with Hcy cblC type. To date, it is not possible to correlate and predict the evolution of every clinical picture. Unfortunately, this study has some limits that reduce the power of the results: first it is a retrospective study that look at patients at different ages and stages of disease, therefore we cannot be entirely certain of the clinical course of macular changes. Second, the limited sample size precludes proper statistical analysis and a prospective and larger study is necessary to better clarify the evolution of the disease. Nevertheless, we believe that our study enriches the knowledge about the pathologic macular changes in cblC disease. Obviously, more functional data and a longer follow-up are necessary to better understand the pathophysiological mechanism of ocular abnormalities in this genetic disorder in order to develop novel therapeutic approaches that may be able to prevent the ocular damage and protect the retinal structures.
